Newsroom
Sorted by: Latest
-
NVIDIA and Corning Announce Long-Term Partnership To Strengthen U.S. Manufacturing for AI Infrastructure
SANTA CLARA, Calif. & CORNING, N.Y.--(BUSINESS WIRE)--NVIDIA (NASDAQ: NVDA) and Corning Incorporated (NYSE: GLW) today announced a multiyear commercial and technology partnership to dramatically expand U.S.-based manufacturing of the advanced optical connectivity solutions needed to power next-generation AI infrastructure. Corning will increase its U.S.-based optical connectivity manufacturing capacity by 10x and expand its U.S. fiber production capacity by more than 50% to meet the acceleratin...
-
Clean Harbors Announces First-Quarter 2026 Financial Results
NORWELL, Mass.--(BUSINESS WIRE)--Clean Harbors, Inc. (“Clean Harbors” or the “Company”) (NYSE: CLH), the leading provider of environmental and industrial services throughout North America, today announced financial results for the first quarter ended March 31, 2026. “We began 2026 with better-than-expected first-quarter results, including higher profitability in both of our operating segments,” said Eric Gerstenberg, Co-Chief Executive Officer. “Our Environmental Services (ES) segment delivered...
-
Tradeweb Reports April 2026 Total Trading Volume of $62.2 Trillion and Average Daily Volume of $2.9 Trillion
NEW YORK--(BUSINESS WIRE)--Tradeweb Markets Inc. (Nasdaq: TW), a global leader in electronic trading across asset classes, today reported total trading volume for the month of April 2026 of $62.2 trillion (tn). Average daily volume ("ADV") for the month was $2.9tn1, an increase of 7.7 percent (%) year-over-year (YoY). Record Highlights: For April of 2026, Tradeweb records included: ADV in fully electronic U.S. high yield credit ADV in U.S. high yield - electronically processed credit ADV in rep...
-
MakeMyTrip Limited to Report Fiscal 2026 Fourth Quarter and Full Year Financial & Operating Results on May 19, 2026
GURUGRAM, India & NEW YORK--(BUSINESS WIRE)--MakeMyTrip Limited to report fiscal 2026 fourth quarter and full year financial & operating results on Tuesday, May 19, 2026....
-
908 Devices Reports First Quarter 2026 Financial Results and Raises 2026 Revenue Outlook
BURLINGTON, Mass.--(BUSINESS WIRE)--908 Devices Inc. (Nasdaq: MASS), a core small-cap growth company focused on purpose-built handheld chemical analysis tools for vital health, safety and defense tech applications, today reported financial results for the quarter ended March 31, 2026. “We delivered a strong start to 2026, achieving 14% revenue growth and meaningful margin expansion,” said Kevin J. Knopp, CEO and Co-founder. “We are also excited to announce the acquisition of NIRLAB AG, a strate...
-
Uncountable Expands Specialty Chemicals Footprint with Four New Deals
SAN FRANCISCO--(BUSINESS WIRE)--Uncountable is helping specialty chemicals organizations modernize how they capture, structure, and leverage data across the product lifecycle....
-
HNI Corporation Reports First Quarter 2026 Results
MUSCATINE, Iowa--(BUSINESS WIRE)--HNI Corporation Reports First Quarter 2026 Results...
-
Lucky Strike Entertainment Reports Third Quarter Results for Fiscal Year 2026
RICHMOND, Va.--(BUSINESS WIRE)--Lucky Strike Entertainment today provided financial results for the third quarter of the 2026 fiscal year, which ended on March 29, 2026....
-
Elisa Expands PON Deployment with Vecima’s All-PON™ Shelf, Delivering 10G Fiber Services in Estonia
VICTORIA, British Columbia--(BUSINESS WIRE)--Vecima announces that leading telecommunications operator Elisa has deployed Vecima’s Entra EXS1610 All-PON Shelf for 10G FTTH services in Estonia....
-
City Therapeutics Presents Preclinical Data on Next-Generation Investigational RNAi Therapy CITY-RBP4 for Treatment of Stargardt Disease at ARVO 2026 Annual Meeting
CAMBRIDGE, Mass.--(BUSINESS WIRE)--City Therapeutics, Inc., a biopharmaceutical company leading the future of RNA interference (RNAi)-based medicine, presented preclinical data for CITY-RBP4, a potentially first-in-class RNAi therapy for the treatment of Stargardt disease, in an oral session today at the Association for Research in Vision and Ophthalmology (ARVO) 2026 Annual Meeting. Stargardt disease type 1 (STGD1), the most prevalent form of inherited macular degeneration, is caused by ABCA4...